CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
Authors
E.S. Dellon Liacouras, C.A. Molina-Infante, J. Furuta, G.T. Spergel, J.M. Zevit, N. Spechler, S.J. Attwood, S.E. Straumann, A. Aceves, S.S. Alexander, J.A. Atkins, D. Arva, N.C. Blanchard, C. Bonis, P.A. Book, W.M. Capocelli, K.E. Chehade, M. Cheng, E. Collins, M.H. Davis, C.M. Dias, J.A. Di Lorenzo, C. Dohil, R. Dupont, C. Falk, G.W. Ferreira, C.T. Fox, A. Gonsalves, N.P. Gupta, S.K. Katzka, D.A. Kinoshita, Y. Menard-Katcher, C. Kodroff, E. Metz, D.C. Miehlke, S. Muir, A.B. Mukkada, V.A. Murch, S. Nurko, S. Ohtsuka, Y. Orel, R. Papadopoulou, A. Peterson, K.A. Philpott, H. Putnam, P.E. Richter, J.E. Rosen, R. Rothenberg, M.E. Schoepfer, A. Scott, M.M. Shah, N. Sheikh, J. Souza, R.F. Strobel, M.J. Talley, N.J. Vaezi, M.F. Vandenplas, Y. Vieira, M.C. Walker, M.M. Wechsler, J.B. Wershil, B.K. Wen, T. Yang, G.-Y. Hirano, I. Bredenoord, A.J.
Publication date
1 January 2018
Publisher
Abstract
Background & Aims: Over the last decade, clinical experiences and research studies raised concerns regarding use of proton pump inhibitors (PPIs) as part of the diagnostic strategy for eosinophilic esophagitis (EoE). We aimed to clarify the use of PPIs in the evaluation and treatment of children and adults with suspected EoE to develop updated international consensus criteria for EoE diagnosis. Methods: A consensus conference was convened to address the issue of PPI use for esophageal eosinophilia using a process consistent with standards described in the Appraisal of Guidelines for Research and Evaluation II. Pediatric and adult physicians and researchers from gastroenterology, allergy, and pathology subspecialties representing 14 countries used online communications, teleconferences, and a face-to-face meeting to review the literature and clinical experiences. Results: Substantial evidence documented that PPIs reduce esophageal eosinophilia in children, adolescents, and adults, with several mechanisms potentially explaining the treatment effect. Based on these findings, an updated diagnostic algorithm for EoE was developed, with removal of the PPI trial requirement. Conclusions: EoE should be diagnosed when there are symptoms of esophageal dysfunction and at least 15 eosinophils per high-power field (or approximately 60 eosinophils per mm2) on esophageal biopsy and after a comprehensive assessment of non-EoE disorders that could cause or potentially contribute to esophageal eosinophilia. The evidence suggests that PPIs are better classified as a treatment for esophageal eosinophilia that may be due to EoE than as a diagnostic criterion, and we have developed updated consensus criteria for EoE that reflect this change. © 2018 AGA Institut
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3107018
Last time updated on 10/02/2023